Log In
Tuesday 25th October 2016

Vitamin D effective against prostate cancer

27th April 2009

A study by Imperial College London has suggested that vitamin D could be used to treat prostate cancer.


Their research showed that the vitamin decreased PSA levels - used to mark the seriousness of the disease - by up to and over 50% in 20% of patients.

The study, published in BJU International, was launched after a patient's condition improved when his wife gave him some vitamin D pills.

The team's head, Professor Jonathan Waxman, stated that this improvement made him interested in exploring the vitamin's effects on more patients.

Vitamin D2 was taken on a daily basis by 26 patients with prostate cancer. Five patients showed positive results.

Two patients' PSA levels went down by over 50%, two had decreased levels of between 25-50% and one had a decrease of less than 25%.

Professor Waxman, from Imperial College London, said vitamin D therapy worked well.

"It's very interesting - there has been no significant trial of vitamin D. This is a treatment which is unlikely to have significant toxicity and is a welcome addition to the therapeutic options for patients with prostate cancer."

Professor Malcolm Mason, a Cancer Research UK prostate cancer expert based at Cardiff University, said the study's findings were interesting but more research was required.

"We advise men with prostate cancer to consult their doctor before taking vitamin D supplements."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016